{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Age&page=98", "query": { "intervention": "Age", "page": 98 }, "page_size": 10 }, "pagination": { "page": 98, "page_size": 10, "total_count": 8279, "total_pages": 828, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Age&page=99&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Age&page=97&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-14T06:55:59.745Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06844214", "title": "A Study to Investigate the Safety, Tolerability, and Efficacy of SAR446268, an Adeno-associated Viral Vector-mediated Gene Therapy in Participants Aged 10 to 55 Years of Age With Non-congenital Myotonic Dystrophy Type 1", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Myotonic Dystrophy" ], "interventions": [ { "name": "SAR446268", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "10 Years to 55 Years" }, "enrollment_count": 32, "start_date": "2025-07-23", "completion_date": "2032-04-27", "has_results": false, "last_update_posted_date": "2026-09-21", "last_synced_at": "2026-11-14T06:55:59.745Z", "location_count": 5, "location_summary": "Gainesville, Florida • Tampa, Florida • New York, New York + 2 more", "locations": [ { "city": "Gainesville", "state": "Florida" }, { "city": "Tampa", "state": "Florida" }, { "city": "New York", "state": "New York" }, { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Richmond", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT06844214" }, { "nct_id": "NCT02955381", "title": "Restylane Silk Acne Scar Efficacy Evaluation Study", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Acne", "Acne Scars", "AdverseEvent" ], "interventions": [ { "name": "Restylane Silk, 1.0 ml", "type": "DEVICE" }, { "name": "Saline, 1.0 ml", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Schweiger Dermatology, PLLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "22 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "22 Years to 55 Years" }, "enrollment_count": 26, "start_date": "2017-03-28", "completion_date": "2019-04-18", "has_results": false, "last_update_posted_date": "2019-05-10", "last_synced_at": "2026-11-14T06:55:59.745Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02955381" }, { "nct_id": "NCT01557244", "title": "A Study To Find Out How Fesoterodine Works In Children Aged 6 To 17 Years With Bladder Overactivity Caused By A Neurological Condition", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Urinary Bladder, Neurogenic" ], "interventions": [ { "name": "Fesoterodine PR 4 mg", "type": "DRUG" }, { "name": "Fesoterodine PR 8 mg", "type": "DRUG" }, { "name": "Oxybutynin", "type": "DRUG" }, { "name": "Fesoterodine PR", "type": "DRUG" }, { "name": "Fesoterodine BIC 2 mg", "type": "DRUG" }, { "name": "Fesoterodine BIC 4 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "6 Years to 17 Years" }, "enrollment_count": 181, "start_date": "2012-07-02", "completion_date": "2020-02-13", "has_results": true, "last_update_posted_date": "2021-02-02", "last_synced_at": "2026-11-14T06:55:59.745Z", "location_count": 18, "location_summary": "Tucson, Arizona • Orange, California • Atlanta, Georgia + 8 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Orange", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01557244" }, { "nct_id": "NCT03586934", "title": "Multimodal Analgesia in Shoulder Arthroplasty", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Shoulder Pain", "Opioid Use" ], "interventions": [ { "name": "Acetaminophen", "type": "DRUG" }, { "name": "Celecoxib 200mg", "type": "DRUG" }, { "name": "Celecoxib 400 mg", "type": "DRUG" }, { "name": "Ropivacaine", "type": "DRUG" }, { "name": "Ketorolac", "type": "DRUG" }, { "name": "Acetaminophen Injectable Product", "type": "DRUG" }, { "name": "Oxycodone", "type": "DRUG" }, { "name": "Tramadol", "type": "DRUG" }, { "name": "Morphine Injectable Solution", "type": "DRUG" }, { "name": "hydrocodone bitartrate and acetaminophen", "type": "DRUG" }, { "name": "Morphine", "type": "DRUG" }, { "name": "Oxycodone Hydrochloride", "type": "DRUG" }, { "name": "Meloxicam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Rush University Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2018-06-01", "completion_date": "2019-06-01", "has_results": false, "last_update_posted_date": "2021-09-28", "last_synced_at": "2026-11-14T06:55:59.745Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT03586934" }, { "nct_id": "NCT05019521", "title": "A Study of Danicopan in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Geographic Atrophy" ], "interventions": [ { "name": "Danicopan", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alexion Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "60 Years", "maximum_age": null, "sex": "ALL", "summary": "60 Years and older" }, "enrollment_count": 365, "start_date": "2021-08-23", "completion_date": "2025-01-21", "has_results": true, "last_update_posted_date": "2025-09-05", "last_synced_at": "2026-11-14T06:55:59.745Z", "location_count": 49, "location_summary": "Phoenix, Arizona • Beverly Hills, California • Encino, California + 45 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Encino", "state": "California" }, { "city": "Fresno", "state": "California" }, { "city": "Fullerton", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05019521" }, { "nct_id": "NCT04771416", "title": "Study of Safety, Tolerability and Efficacy of PBKR03 in Pediatric Subjects With Early Infantile Krabbe Disease", "overall_status": "SUSPENDED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Leukodystrophy, Globoid Cell" ], "interventions": [ { "name": "PBKR03", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Gemma Biotherapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Month", "maximum_age": "9 Months", "sex": "ALL", "summary": "1 Month to 9 Months" }, "enrollment_count": 24, "start_date": "2022-02-24", "completion_date": "2030-01", "has_results": false, "last_update_posted_date": "2026-06-30", "last_synced_at": "2026-11-14T06:55:59.745Z", "location_count": 4, "location_summary": "Chicago, Illinois • New York, New York • Philadelphia, Pennsylvania + 1 more", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "New York", "state": "New York" }, { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT04771416" }, { "nct_id": "NCT04201704", "title": "Effect of Giving Reduced Fluid in Children After Trauma", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Critical Illness", "Pediatrics", "General Surgery", "Fluid Therapy", "Wounds and Injuries" ], "interventions": [ { "name": "Balanced crystalloid solution volume administration", "type": "OTHER" }, { "name": "Packed Erythrocytes Units, Blood Product Unit volume", "type": "OTHER" }, { "name": "Plasma volume", "type": "OTHER" }, { "name": "Platelets volume", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Columbia University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Months", "maximum_age": "15 Years", "sex": "ALL", "summary": "6 Months to 15 Years" }, "enrollment_count": 250, "start_date": "2018-08-27", "completion_date": "2027-09", "has_results": false, "last_update_posted_date": "2026-05-07", "last_synced_at": "2026-11-14T06:55:59.745Z", "location_count": 4, "location_summary": "Buffalo, New York • New York, New York • Rochester, New York + 1 more", "locations": [ { "city": "Buffalo", "state": "New York" }, { "city": "New York", "state": "New York" }, { "city": "Rochester", "state": "New York" }, { "city": "Memphis", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT04201704" }, { "nct_id": "NCT06003192", "title": "Screen Smart: Using Digital Health to Improve HIV Screening and Prevention", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "HIV Infections" ], "interventions": [ { "name": "Universal Opt-out HIV Screening", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Children's Hospital Medical Center, Cincinnati", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "15 Years", "maximum_age": "21 Years", "sex": "ALL", "summary": "15 Years to 21 Years" }, "enrollment_count": 63000, "start_date": "2024-12-16", "completion_date": "2028-03-15", "has_results": false, "last_update_posted_date": "2026-10-23", "last_synced_at": "2026-11-14T06:55:59.745Z", "location_count": 4, "location_summary": "Columbus, Ohio • Philadelphia, Pennsylvania • Salt Lake City, Utah + 1 more", "locations": [ { "city": "Columbus", "state": "Ohio" }, { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Salt Lake City", "state": "Utah" }, { "city": "Milwaukee", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT06003192" }, { "nct_id": "NCT06805799", "title": "Stress Reactivity and Mother-Infant Cardiovascular Disease Risk", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Maternal Health", "Infant Health", "Hypertension", "Behavioral Medicine", "Mindfulness", "Psychophysiology", "Cardiovascular Diseases", "Cardiovascular Diseases Risk" ], "interventions": [ { "name": "Follow up to Mindfulness RCT using a Still Face Paradigm", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Lifespan", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Months", "maximum_age": null, "sex": "FEMALE", "summary": "6 Months and older · Female only" }, "enrollment_count": 5, "start_date": "2026-06-11", "completion_date": "2026-07-31", "has_results": false, "last_update_posted_date": "2026-11-13", "last_synced_at": "2026-11-14T06:55:59.745Z", "location_count": 1, "location_summary": "Providence, Rhode Island", "locations": [ { "city": "Providence", "state": "Rhode Island" } ], "official_url": "https://clinicaltrials.gov/study/NCT06805799" }, { "nct_id": "NCT01337232", "title": "Building Complex Language", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Language Development Disorders", "Learning Disorders" ], "interventions": [ { "name": "Complex sentence treatment protocol", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Governors State University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": "14 Years", "sex": "ALL", "summary": "10 Years to 14 Years" }, "enrollment_count": 31, "start_date": "2011-04", "completion_date": "2013-09", "has_results": false, "last_update_posted_date": "2013-11-25", "last_synced_at": "2026-11-14T06:55:59.745Z", "location_count": 2, "location_summary": "Chicago, Illinois • University Park, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "University Park", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT01337232" } ] }